Louis Lacombe

Hôtel-Dieu de Québec

Papers

2

Total Citations

21

H-Index

2

About

Dr. Louis Lacombe is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes for prostate and kidney cancers, with a particular focus on minimally invasive techniques and perioperative patient management. His major contributions include landmark research on partial nephrectomy, where his 2020 study (18 citations) systematically compared open and minimally invasive approaches, demonstrating that the "trifecta" of optimal oncologic, functional, and safety outcomes is achievable with both techniques when performed by experienced surgeons. This work has helped guide surgical decision-making for renal cell carcinoma. Dr. Lacombe has also investigated the controversial role of omega-3 fatty acid supplementation before radical prostatectomy, challenging conventional wisdom by suggesting these supplements may not increase perioperative bleeding risk—a finding with significant implications for patient counseling and preoperative protocols. His research bridges the gap between surgical technique and evidence-based perioperative care, directly impacting clinical practice. With a career dedicated to refining urologic oncology surgery, Dr. Lacombe continues to shape how surgeons approach complex kidney and prostate procedures, emphasizing both technical excellence and patient-centered outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
21
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Achieving the “trifecta” with open versus minimally invasive partial nephrectomy
18 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: Hôtel-Dieu de Québec

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago